Quality Control Chemist

The petition was approved based on the satisfaction of at least three EB-1A criteria: authorship of scholarly articles, participation as a judge of the work of others, and original scientific contributions of major significance. Specific metrics included 8 peer-reviewed publications in elite journals like Nature Microbiology, 260 citations placing him in the top 1% of his field, and the completion of over 20 peer reviews for high-impact journals.

The petition was approved based on the petitioner's authorship of 27 peer-reviewed articles and 17 abstracts, which garnered 485 citations from researchers in over 40 countries. His work ranked in the top 10% of most-cited publications in pharmacology for several years. Additionally, he completed over 60 peer reviews and received research grants from the NIH and the National Research Foundation of South Korea.

The petition was approved based on meeting at least three EB-1A criteria: authorship of 13 peer-reviewed journal articles and a conference paper, serving as a reviewer for at least 12 manuscripts, and demonstrating original contributions through 254 citations from 27 countries. Additionally, the petitioner secured significant research funding from the FDA, USP, and NSF, further validating his leading role and expertise.

The petition was approved based on 15 peer-reviewed journal articles, 3 abstracts, and 1 book chapter which garnered 591 independent citations. The petitioner satisfied EB-1A criteria through his scholarly articles in high-impact journals like ACS Nano, his role as a judge for at least 20 peer reviews, and his original scientific contributions to organic chemistry. His work was further validated by its alignment with federally supported research funded by the NIH, DOD, and NSF.